Sign in
4

Changes in Ownership

Mereo BioPharma Group plc Filed Acc 0000950170-24-078467

Chief Financial Officer sold 42,429 shares at an average $3.49 ($147,876)

From the SEC's structured data for this filing

Trades in this filing

Fox Christine Ann · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-06-25 Sale : show line 1 in the form −12,990 $3.69 $47,984 87,010 D
2024-06-26 Sale : show line 2 in the form −29,439 $3.39 $99,892 57,571 D
Open-market sales · 42,429 sh · avg $3.49 · $147,876
Loading xslF345X05/ownership.xml…